Rep. Elijah Cummings, D-Md., chairman of the House Oversight Committee, sent letters to a dozen drugmakers requesting detailed information about their pricing practices as part of an investigation into high prescription drug prices. The request focused on drugs that are especially costly to Medicare Part D and those with the largest five-year price increases.
House committee kicks off drug-pricing investigation
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.